PRESSR: Leading MENA healthtech Almouneer partners with the international medical center, to revolutionize ophthalmic care in Egypt

First published: 22-May-2024 10:56:40

Patients will have immediate access to world-leading experts and innovative treatments 

Cairo, Egypt: The International Medical Center (“IMC”), the Middle East and Africa’s (MEA) leading and most advanced medical facility, and Almouneer, the leading MEA HealthTech for Ophthalmology and Diabetes management (dru)  announce a new partnership to provide consultant-led medical services - with top-tier experts serving patients across the region and aligning with President Abdel Fattah El-Sisi’s Egypt Vision 2030’s health pillar and the Digital Egypt strategy by furthering access to high quality healthcare through greater digitalization.

The partnership – under the leadership of Major General Professor Dr. Hisham M. El Shishtawy, the General Manager of International Medical Center, and Professor Dr. Noha Khater, Chief Executive Officer and Chief Medical Officer of Almouneer – will combine the IMC’s comprehensive and innovative medical capabilities and facilities with Almouneer's pioneering digital health technologies and expertise in Ophthalmology and Diabetes care. 

Patients will have access to Almouneer’s advanced software and extensive international network of top-tier consultants – including the region’s first bilingual Arabic / English health companion app dru. The partnership will see the clinic become a leading center of excellence in Surgical interventions in Ophthalmology with particular focus on Corneal transplant surgery and Diabetic Eyecare management within the region. The world-renowned consultants will examine patients, determine the required treatment options and surgical procedures - using the most advanced technologies only available at the IMC.

Almouneer’s innovative approach includes its custom-developed practice and patient management platforms, NoRa, which integrate seamlessly with medical diagnostics and imaging through innovative open APIs aligned to the global industry standard HISS and gathering data from the latest wearable devices that can log healthcare metrics with the potential to further integrate AI – streamlining patient management and enhancing treatment outcomes.

Dr. Noha Khater, CEO and Co-Founder of Almouneer, said: 

“This partnership with IMC is a milestone for Almouneer. We are combining our expertise in Ophthalmology, Chronic disease management especially Diabetes, and digital health solutions with Egypt’s leading and most advanced medical facility. Our commitment is to provide exceptional care and continuous innovation - to enhance patient outcomes.”

The partnership will set a new standard in medical services in Egypt, and across the MEA region. Almouneer and IMC anticipate the integration of advanced medical and digital health technologies will lead to improved patient care and satisfaction.

Further information

Thoburns (for Almouneer)

Simran Randhawa

s.randhawa@thoburns.com

+44 7564 584 423

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.